A MUM has revealed the surprising side benefit of using skinny jabs – and it’s proved just as life-changing as shedding 7st. Emma Clark, from Hamilton, Lanarkshire, started using ...

Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

Ozempic (semaglutide ... and Victoza are not approved for weight loss or weight management. However, some people using Ozempic and Victoza in studies did lose weight. (Although in certain studies ...

Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged ...

Specialists in obesity medicine play a crucial role in creating treatment strategies that help patients lose weight while maintaining ... the GLP-1 receptor agonist semaglutide or the dual GLP ...

New study finds potential link between GLP1 agonists and depression, urging further investigation into patient safety.

The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...

At the least, the new 7.2mg results point to scope for hiking the semaglutide dose in CagriSema to chase down that weight-loss target. The company is also running a phase 3b trial of 7.2mg ...

The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, according to a research letter published ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

"So many patients are taking GLP-1s at doses that are too high, silencing their body's natural signals and developing side effects like fatigue, hair loss, and rebound weight gain. The DROP Method ...